Joseph Truitt, iECURE CEO

Ex­clu­sive: Jim Wil­son start­up gets FDA green light for first test of gene edit­ing in ba­bies

Near­ly 25 years ago, a young man with an in­her­it­ed liv­er dis­ease died from a vi­cious im­mune re­ac­tion to an ex­per­i­men­tal gene ther­a­py. Now Jim …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.